Maura Cosseddu1, Alberto Benussi2, Stefano Gazzina2, Rosanna Turrone2, Silvana Archetti3, Elisa Bonomi2, Giorgio Biasiotto3,4, Isabella Zanella3,4, Raffaele Ferrari5, Maria S Cotelli6, Antonella Alberici2, Alessandro Padovani2, Barbara Borroni2. 1. a Neurology Unit , Spedali Civili Hospital , Brescia , Italy. 2. b Centre for Ageing Brain and Neurodegenerative Disorders, Neurology Unit, Department of Clinical and Experimental Sciences , University of Brescia , Brescia , Italy. 3. c Biotechnology Laboratory and Department of Diagnostics , Civic Hospital of Brescia , Brescia , Italy. 4. d Department of Molecular and Translational Medicine , University of Brescia , Brescia , Italy. 5. e Department of Molecular Neuroscience , Institute of Neurology, University College London , London , UK , and. 6. f Neurology Unit , Vallecamonica Hospital , Brescia , Italy.
Abstract
OBJECTIVE: Frontotemporal dementia (FTD) is a common cause of young onset dementia. Very few reports on disease duration are currently available and predictors of survival are still undefined. The aim of the present study was to assess the natural history of FTD and to define predictors of survival. METHODS: Four hundred amd eleven FTD patients, including 294 with behavioural variant FTD, 77 with agrammatic variant primary progressive aphasia (PPA) and 40 with semantic variant PPA, were consecutively enrolled and demographic and clinical variables carefully recorded. Each patient underwent genetic screening for monogenic disease. RESULTS: The mean survival time from onset of the symptoms was 7.8 ± 4.0 years. The presence of a pathogenic mutation (GRN, C9orf72 or MAPT) (Hazard ratio [HR] = 1.85, 95% CI 1.04-3.31, p = 0.037) and older age at disease onset (HR = 1.04, 95% CI 1.02-1.07, p = 0.002) were associated with shorter life expectancy. However, a significant negative interaction between age at onset and genetic mutation was found, suggesting that the effect of age is different in patients with and without a genetic mutation (p = 0.028). Gender, clinical phenotype or education and occupation were not associated with survival risk. CONCLUSIONS: Our findings suggest that monogenic disease and age at onset are independent predictors of survival and should be considered in future clinical intervention trials and in patients' and caregivers' counselling.
OBJECTIVE: Frontotemporal dementia (FTD) is a common cause of young onset dementia. Very few reports on disease duration are currently available and predictors of survival are still undefined. The aim of the present study was to assess the natural history of FTD and to define predictors of survival. METHODS: Four hundred amd eleven FTDpatients, including 294 with behavioural variant FTD, 77 with agrammatic variant primary progressive aphasia (PPA) and 40 with semantic variant PPA, were consecutively enrolled and demographic and clinical variables carefully recorded. Each patient underwent genetic screening for monogenic disease. RESULTS: The mean survival time from onset of the symptoms was 7.8 ± 4.0 years. The presence of a pathogenic mutation (GRN, C9orf72 or MAPT) (Hazard ratio [HR] = 1.85, 95% CI 1.04-3.31, p = 0.037) and older age at disease onset (HR = 1.04, 95% CI 1.02-1.07, p = 0.002) were associated with shorter life expectancy. However, a significant negative interaction between age at onset and genetic mutation was found, suggesting that the effect of age is different in patients with and without a genetic mutation (p = 0.028). Gender, clinical phenotype or education and occupation were not associated with survival risk. CONCLUSIONS: Our findings suggest that monogenic disease and age at onset are independent predictors of survival and should be considered in future clinical intervention trials and in patients' and caregivers' counselling.
Authors: Carrie Caswell; Corey T McMillan; Sharon X Xie; Vivianna M Van Deerlin; EunRan Suh; Edward B Lee; John Q Trojanowski; Virginia M-Y Lee; David J Irwin; Murray Grossman; Lauren M Massimo Journal: Neurology Date: 2019-09-19 Impact factor: 9.910
Authors: Jay L P Fieldhouse; Flora T Gossink; Thomas C Feenstra; Sterre C M de Boer; Afina W Lemstra; Niels D Prins; Femke Bouwman; Ted Koene; Hanneke F M Rhodius-Meester; Freek Gillissen; Charlotte E Teunissen; Wiesje M van der Flier; Philip Scheltens; Annemieke Dols; Everard G B Vijverberg; Yolande A L Pijnenburg Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.472
Authors: Qin Chen; Bradley F Boeve; Nirubol Tosakulwong; Timothy Lesnick; Danielle Brushaber; Christina Dheel; Julie Fields; Leah Forsberg; Ralitza Gavrilova; Debra Gearhart; Dana Haley; Jeffrey L Gunter; Jonathan Graff-Radford; David Jones; David Knopman; Neill Graff-Radford; Ruth Kraft; Maria Lapid; Rosa Rademakers; Jeremy Syrjanen; Zbigniew K Wszolek; Howie Rosen; Adam L Boxer; Kejal Kantarci Journal: Neurology Date: 2019-07-17 Impact factor: 11.800
Authors: Katrina M Moore; Jennifer Nicholas; Murray Grossman; Corey T McMillan; David J Irwin; Lauren Massimo; Vivianna M Van Deerlin; Jason D Warren; Nick C Fox; Martin N Rossor; Simon Mead; Martina Bocchetta; Bradley F Boeve; David S Knopman; Neill R Graff-Radford; Leah K Forsberg; Rosa Rademakers; Zbigniew K Wszolek; John C van Swieten; Lize C Jiskoot; Lieke H Meeter; Elise Gp Dopper; Janne M Papma; Julie S Snowden; Jennifer Saxon; Matthew Jones; Stuart Pickering-Brown; Isabelle Le Ber; Agnès Camuzat; Alexis Brice; Paola Caroppo; Roberta Ghidoni; Michela Pievani; Luisa Benussi; Giuliano Binetti; Bradford C Dickerson; Diane Lucente; Samantha Krivensky; Caroline Graff; Linn Öijerstedt; Marie Fallström; Håkan Thonberg; Nupur Ghoshal; John C Morris; Barbara Borroni; Alberto Benussi; Alessandro Padovani; Daniela Galimberti; Elio Scarpini; Giorgio G Fumagalli; Ian R Mackenzie; Ging-Yuek R Hsiung; Pheth Sengdy; Adam L Boxer; Howie Rosen; Joanne B Taylor; Matthis Synofzik; Carlo Wilke; Patricia Sulzer; John R Hodges; Glenda Halliday; John Kwok; Raquel Sanchez-Valle; Albert Lladó; Sergi Borrego-Ecija; Isabel Santana; Maria Rosário Almeida; Miguel Tábuas-Pereira; Fermin Moreno; Myriam Barandiaran; Begoña Indakoetxea; Johannes Levin; Adrian Danek; James B Rowe; Thomas E Cope; Markus Otto; Sarah Anderl-Straub; Alexandre de Mendonça; Carolina Maruta; Mario Masellis; Sandra E Black; Philippe Couratier; Geraldine Lautrette; Edward D Huey; Sandro Sorbi; Benedetta Nacmias; Robert Laforce; Marie-Pier L Tremblay; Rik Vandenberghe; Philip Van Damme; Emily J Rogalski; Sandra Weintraub; Alexander Gerhard; Chiadi U Onyike; Simon Ducharme; Sokratis G Papageorgiou; Adeline Su Lyn Ng; Amy Brodtmann; Elizabeth Finger; Rita Guerreiro; Jose Bras; Jonathan D Rohrer Journal: Lancet Neurol Date: 2019-12-03 Impact factor: 44.182
Authors: Alberto Benussi; Nicholas J Ashton; Thomas K Karikari; Antonella Alberici; Claudia Saraceno; Roberta Ghidoni; Luisa Benussi; Henrik Zetterberg; Kaj Blennow; Barbara Borroni Journal: Alzheimers Res Ther Date: 2021-11-15 Impact factor: 6.982